Wow look at all the shares trading pre-market on this news...truly amazing.----sarcasm
If Amarin isn't extremely aggressive at oral arguments the above trend may never turn around until FDA on-label and income is pouring in. I don't expect the stock will trade $3.40's to $20 until Amarin has an aggressive win and beat down against the Federal governments handling of Amarin & Vascepa.
The FDA has wasted $Billions in unneeded medical expenses and has placed an entire population into the R-I trial without consent, this is the direct result of the ANCHOR SPA rescindment.